Antimicrobial Disinfectants, Respiratory Support, and Infectious Disease Management
This community investigates the clinical efficacy of chemical disinfectants and antimicrobial agents, the management of acute respiratory distress, and the treatment of specific bacterial and viral infections.
The work centers on evaluating povidone-iodine, quaternary ammonium compounds, and benzalkonium chloride for their activity against pathogens such as Staphylococcus aureus, Listeria monocytogenes, and Escherichia coli. A significant portion of the research addresses the prevention of surgical site infections and the formation of biofilms on stainless steel and medical surfaces. Concurrently, the community tracks the clinical application of high-flow nasal oxygen therapy and nasal cannulas for patients with acute respiratory distress syndrome and severe respiratory infections. The literature includes a substantial volume of randomized controlled trials, systematic meta-analyses, and case reports focused on the efficacy of these interventions against SARS-CoV-2 and other respiratory viruses, as well as the broader management of pandemic-related respiratory complications.
The largest share of the community's output is found in iodine research, accounting for 3.1% of all iodine research, and 5,289 papers here. This is followed by chlorine, which contributes 0.6% of its research, and oxygen, contributing 0.3%.
The community comprises 23,665 papers, with the most frequent venues being Dermatologic Therapy, bioRxiv (Cold Spring Harbor Laboratory), and Signal Transduction and Targeted Therapy.
Recent work explores disinfectant-induced bacterial resistance and antibiotic cross-resistance, the design of phage cocktails for effective pathogen control, and the development of cationic amphiphilic disinfectants.